首页> 外文期刊>癌と化学療法 >An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1
【24h】

An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1

机译:每两周一次紫杉醇和TS-1联合化疗可有效治疗无法切除的晚期胃癌,该胃癌具有Virchow转移,癌性腹水和直肠狭窄。

获取原文
获取原文并翻译 | 示例
           

摘要

A 43-year-old woman who complained of abdominal fullness, appetite loss, and constipation was diagnosed as unresectable advanced schirrhous gastric cancer with left supra-clavicular lymph node metastases, massive ascites, rectal stenosis, and bilateral hydronephrosis due to peritoneal metastases. The biopsy specimen showed a poorly differentiated adenocarcinoma with signet-ring cells. After placement of the bilateral ureteral stents, she was treated with combined chemotherapy of biweekly paclitaxel (120 mg/m2, day 1, day 15) and TS-1 (80 mg/day, days 1-14 with 2-weeks rest). Subjective symptoms were relieved after one course of the chemotherapy. After 3 courses, computed tomography showed markedly reduced supra-clavicular lymph node metastases and no ascites. Radiographic and endoscopic examinations also demonstrated remarkable improvements in compliance of the gastric and rectal walls. These findings suggested that partial response on Response Evaluation Criteria in Solid Tumors (RECIST) was obtained.After the first course, the treatment was continued on an outpatient basis. There were no adverse effects over grade 2 throughout six courses of the chemotherapy. The biweekly paclitaxel and TS-1 chemotherapy may well be an effective treatment for advanced schirrhous gastric cancer with carcinomatous peritonitis.
机译:一名43岁的女性因腹部饱满,食欲不振和便秘而被诊断为无法切除的晚期紫癜性胃癌,伴有左锁骨上淋巴结转移,大量腹水,直肠狭窄和腹膜转移引起的双侧肾积水。活检标本显示具有印戒细胞的低分化腺癌。放置双侧输尿管支架后,她接受了每两周一次的紫杉醇(120 mg / m2,第1天,第15天)和TS-1(80 mg /天,第1-14天,休息2周)的联合化疗。化疗一疗程后主观症状得到缓解。 3个疗程后,计算机断层扫描显示锁骨上淋巴结转移明显减少,且无腹水。射线照相和内窥镜检查还显示出胃壁和直肠壁顺应性的显着改善。这些发现表明,获得了对实体瘤反应评估标准(RECIST)的部分反应。第一疗程后,在门诊患者基础上继续治疗。在整个六个疗程中,没有超过2级的不良反应。每两周一次紫杉醇和TS-1化疗可能是晚期伴发癌性腹膜炎的先天性胃癌的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号